Analysis of the role of CADM1 in malignant progression of small-cell lung cancer using Rb1/ Trp53-floxed mouse models

被引：0
|
作者：
Tominaga, Mizuki [1 ]
Funaki, Toko [1 ]
Ito, Takeshi [1 ]
Murakami, Yoshinori [1 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3004
引用
收藏
页码：1834 / 1834
页数：1
相关论文
共 50 条
  • [41] Comparative study of Rb1, cyclin D1 and p16 immunohistochemistry expression to distinguish lung small-cell carcinoma and large-cell neuroendocrine carcinoma
    Papaxoinis, G.
    Bille, A.
    McLean, E.
    Nonaka, D.
    HISTOPATHOLOGY, 2022, 81 (02) : 205 - 214
  • [42] Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer cells
    Hokari, Satoshi
    Tamura, Yusuke
    Kaneda, Atsushi
    Katsura, Akihiro
    Morikawa, Masato
    Ehata, Shogo
    Tsutsumi, Shuichi
    Ishikawa, Yuichi
    Aburatani, Hiroyuki
    Kikuchi, Toshiaki
    Miyazono, Kohei
    Koinuma, Daizo
    CANCER SCIENCE, 2021, 112 : 297 - 297
  • [43] MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer
    Feiye Liu
    Yanjun Cai
    Xiaoxiang Rong
    Jinzhang Chen
    Dayong Zheng
    Lu Chen
    Junyi Zhang
    Rongcheng Luo
    Peng Zhao
    Jian Ruan
    Molecular Cancer, 16
  • [44] MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer
    Liu, Feiye
    Cai, Yanjun
    Rong, Xiaoxiang
    Chen, Jinzhang
    Zheng, Dayong
    Chen, Lu
    Zhang, Junyi
    Luo, Rongcheng
    Zhao, Peng
    Ruan, Jian
    MOLECULAR CANCER, 2017, 16
  • [45] Identification of DJ-1 as a contributor to multidrug resistance in human small-cell lung cancer using proteomic analysis
    Gao, Hongyi
    Niu, Yuchun
    Li, Man
    Fang, Shun
    Guo, Linlang
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2017, 98 (02) : 67 - 74
  • [46] The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis
    Gao, Fei
    Zhou, Bin
    Xu, Jun-Chi
    Gao, Xin
    Li, Shu-Xiang
    Zhu, Geng-Chao
    Zhang, Xue Guang
    Yang, Chen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 462 (02) : 91 - 98
  • [47] Niraparib, a selective PARP 1/2 inhibitor, is efficacious in pre-clinical models of small-cell lung cancer
    Wang, Y.
    Ricono, J.
    Admunson, K.
    Agarwal, S.
    Fram, R. J.
    Broudy, T.
    Wilcoxen, K. M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 80 - 81
  • [48] Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer
    Shibaki, Ryota
    Fujimoto, Daichi
    Nozawa, Tsukasa
    Sano, Akira
    Kitamura, Yuka
    Fukuoka, Junya
    Sato, Yuki
    Kijima, Takashi
    Matsumoto, Hirotaka
    Yokoyama, Toshihide
    Miura, Satoru
    Hata, Akito
    Tamiya, Motohiro
    Taniguchi, Yoshihiko
    Sugisaka, Jun
    Furuya, Naoki
    Tanaka, Hisashi
    Yamamoto, Nobuyuki
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)
  • [49] Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1-Deficient Human and Mouse Small-Cell Lung Cancer
    Zhao, Hongling
    Iqbal, Niloy J.
    Sukrithan, Vineeth
    Nicholas, Cari
    Xue, Yingjiao
    Yu, Cindy
    Locker, Joseph
    Zou, Juntao
    Schwartz, Edward L.
    Zhu, Liang
    CANCER RESEARCH, 2020, 80 (11) : 2355 - 2367
  • [50] Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series
    Gupta, Ashish
    Jatwani, Karan
    Gupta, Kush
    Qiu, Jingxin
    Dy, Grace K.
    JCO PRECISION ONCOLOGY, 2023, 7
12345